詹姆斯哈迪 JHX 深滬

已收盤 02-06 16:00:00 美东时间

23.64

+0.690

+3.01%

華盛通

立即下載

最高23.67
今開23.03
成交量 644.11万股
最低 22.73
昨收 22.95
總市值 137.09亿
52周最高 32.99
市盈率 ^靜 24.09
換手率 1.11%
52周最低 16.46
委比 -11.72%
總股本 5.80亿
歷史最高 43.57
量比 0.93
振幅 4.10%
歷史最低 2.417
每手 1
風險率 4.22%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

美股大行评级 | 潜在涨幅2566.67%！Ascendiant Capital上调GRI Bio目标价至36美元，维持"买入"评级

今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从35美元升至36美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.75美元升至8美元

2025-12-09 10:32
Barclays Initiates Coverage On James Hardie Industries with Equal-Weight Rating, Announces Price Target of $21

Barclays analyst Matthew Bouley initiates coverage on James Hardie Industries (NYSE:JHX) with a Equal-Weight rating and announces Price Target of $21.

2025-12-08 20:18
Hagens Berman Investigating Jamies Hardie (JHX) After 34% Plunge Due to Inventory Destocking

JHX Investors with Losses Encouraged to Contact Firm SAN FRANCISCO, Dec. 3, 2025 /PRNewswire/ -- National shareholder rights law firm Hagens Berman reminds investors that the deadline to mov...

2025-12-04 04:05
美股大行评级 | 高盛上调百度、美敦力、晶科能源等多只个股目标价；家得宝遭9家机构下调目标价；

今日重点评级关注：富国银行：维持Annexon"超配"评级，目标价从14美元升至27美元；瑞穗：上调Relmada Therapeutics评级至"跑赢大市"，目标价从1美元升至10美元

2025-11-20 10:28
美股盘后 | 詹姆斯哈迪涨13.24%

詹姆斯哈迪涨13.24%，报18.9美元

2025-11-18 06:01
James Hardie Appoints Nigel Stein As Board Chair And Forms Integration & Performance Committee

Forms Integration and Performance Committee of the BoardJames Hardie Industries plc (NYSE/ASX: JHX) ("James Hardie" or the "Company"), a leading provider of exterior home and outdoor living solutions, today announced the

2025-11-18 05:43
Citigroup Upgrades James Hardie Industries to Buy

Citigroup analyst Samuel Seow upgrades James Hardie Industries (NYSE:JHX) from Neutral to Buy.

2025-11-04 20:10
华尔街顶级分析师最新评级报告：联合健康遭下调

　　华尔街最受关注、且能影响市场走势的研究评级报告现已汇总于此。以下是由 The Fly 整理的今日投资者需重点关注的评级信息。五大评级上调案例思佳讯...

2025-10-29 22:12
James Hardie Industries (JHX) Lawsuit Alleges Securities Fraud Over Inventory Misstatements -- Hagens Berman

SAN FRANCISCO, Oct. 27, 2025 /PRNewswire/ -- A class-action lawsuit has been filed against James Hardie Industries plc (NYSE: JHX), the dominant producer of fiber cement building materials i...

2025-10-28 05:58

派息除權日	每股總股息	派息日期
2022-05-26	0.22	2022-07-29
2021-11-18	0.29	2021-12-17
2021-02-18	0.51	2021-04-30
2019-11-15	0.07	2019-12-20
2019-06-05	0.20	2019-08-02
2018-12-11	0.07	2019-02-22
2018-06-06	0.30	2018-08-03
2017-12-12	0.07	2018-02-23
2017-06-06	0.21	2017-08-04
2016-12-19	0.08	2017-02-24
2016-06-07	0.23	2016-08-05
2015-12-21	0.07	2016-02-26
2015-06-09	1.94	2015-08-07
2014-12-18	0.30	2014-12-22
2014-06-10	2.58	2014-08-08
2014-03-18	1.38	2014-05-30
2013-12-16	0.38	2014-03-28
2013-06-25	1.83	2013-07-26
2012-12-13	0.22	2013-01-25
2012-06-26	1.88	2012-07-23
2011-12-13	0.18	2012-01-23
2008-05-30	0.32	2008-07-11
2007-11-29	0.49	2007-12-18
2007-06-11	0.62	2007-07-13
2006-12-12	0.46	2007-01-08
2006-06-09	0.15	2006-07-06
2005-11-23	0.15	2005-12-16
2005-06-06	0.22	2005-07-05
2004-06-07	0.11	2004-07-02
2003-11-24	0.09	2003-12-17
2003-11-05	0.75	2003-11-20
2003-06-09	0.09	2003-07-03
2003-01-09	0.09	2003-02-05
2002-10-09	0.19	2002-11-04
2001-12-03	0.25	2001-12-21
2001-05-23	0.08	2001-06-25
2000-11-27	0.09	2000-12-26

公司名稱	詹姆斯哈迪
行業分類	建筑材料
業務描述	James Hardie Industries Plc engages in the provision of fiber cement and fiber gypsum building solutions. It operates through the following segments: North America Fiber Cement, Asia Pacific Fiber Cement, Europe Building Products, and Research and Development. The North America Fiber Cement segment manufactures fiber cement interior linings, exterior siding products, and related accessories in the United States; these products are sold in the United States and Canada. The Asia Pacific Fiber Cement segment includes all fiber cement products manufactured in Australia and the Philippines, and sold in Australia, New Zealand, Asia, the Middle East and Pacific Islands. The Europe Building Products segment encompasses the Fermacell business and fiber cement product manufactured in the United States that is sold in Europe. The Research and Development segment represents the cost incurred by the research and development centers. The company was founded in 1888 and is headquartered in Dublin, Ireland.

詹姆斯哈迪 JHX 深 滬

23.64

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

詹姆斯哈迪 JHX 深滬